SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BORGATTI, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.687
AS - Asia 15.074
EU - Europa 12.293
SA - Sud America 2.453
AF - Africa 336
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 55.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.152
SG - Singapore 5.538
FI - Finlandia 4.212
CN - Cina 4.067
BR - Brasile 1.958
IT - Italia 1.753
VN - Vietnam 1.545
DE - Germania 1.320
HK - Hong Kong 1.203
UA - Ucraina 1.197
PL - Polonia 1.181
TR - Turchia 815
GB - Regno Unito 750
FR - Francia 487
SE - Svezia 476
RU - Federazione Russa 372
JP - Giappone 362
IN - India 324
CA - Canada 252
ID - Indonesia 235
BD - Bangladesh 227
MX - Messico 199
AR - Argentina 173
NL - Olanda 131
ZA - Sudafrica 119
IQ - Iraq 103
PK - Pakistan 96
EC - Ecuador 87
ES - Italia 82
CO - Colombia 66
PH - Filippine 61
BE - Belgio 59
IR - Iran 57
MY - Malesia 54
UZ - Uzbekistan 54
VE - Venezuela 54
MA - Marocco 47
SA - Arabia Saudita 46
LT - Lituania 43
CL - Cile 42
AT - Austria 39
AE - Emirati Arabi Uniti 38
TN - Tunisia 33
AU - Australia 32
PY - Paraguay 32
KE - Kenya 30
EG - Egitto 28
KR - Corea 28
CZ - Repubblica Ceca 27
CH - Svizzera 26
GR - Grecia 24
TH - Thailandia 22
JO - Giordania 21
IL - Israele 17
ET - Etiopia 16
IE - Irlanda 16
NP - Nepal 16
TW - Taiwan 16
JM - Giamaica 15
OM - Oman 15
PE - Perù 15
AZ - Azerbaigian 14
DZ - Algeria 14
LB - Libano 14
RO - Romania 14
KZ - Kazakistan 13
CR - Costa Rica 12
PA - Panama 12
UY - Uruguay 12
BO - Bolivia 11
PT - Portogallo 11
DO - Repubblica Dominicana 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
BH - Bahrain 9
KG - Kirghizistan 9
LV - Lettonia 9
LY - Libia 8
NG - Nigeria 8
PS - Palestinian Territory 8
RS - Serbia 8
TT - Trinidad e Tobago 8
AL - Albania 7
KW - Kuwait 7
SI - Slovenia 7
AO - Angola 6
GE - Georgia 6
MN - Mongolia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
EU - Europa 5
HU - Ungheria 5
MD - Moldavia 5
CY - Cipro 4
EE - Estonia 4
GT - Guatemala 4
HN - Honduras 4
KH - Cambogia 4
NI - Nicaragua 4
SN - Senegal 4
Totale 55.822
Salva come PNG Salva come JPEG
Città #
Helsinki 3.850
Singapore 3.438
Ashburn 2.908
Woodbridge 2.258
Fairfield 1.902
San Jose 1.732
Beijing 1.444
Chandler 1.407
Jacksonville 1.365
Ann Arbor 1.296
Houston 1.222
Hong Kong 1.179
Warsaw 1.163
Santa Clara 1.077
Wilmington 802
Seattle 778
Cambridge 628
Ferrara 514
Ho Chi Minh City 506
Izmir 477
Nanjing 425
New York 418
Los Angeles 397
Dallas 389
Hanoi 360
Tokyo 340
Princeton 326
Lauterbourg 273
Munich 255
Boardman 232
Council Bluffs 184
Shanghai 177
Milan 164
Jakarta 162
San Diego 156
São Paulo 155
Bremen 154
Addison 150
Bologna 135
Nanchang 123
Shenyang 120
Mexico City 119
Orem 106
London 97
Tianjin 93
Turku 93
Changsha 85
Hebei 84
Redwood City 82
Brooklyn 81
Porto Alegre 79
Chennai 78
Da Nang 75
Hefei 74
Montreal 74
Falls Church 73
Rio de Janeiro 73
Jiaxing 68
Frankfurt am Main 67
Moscow 66
Denver 65
Buffalo 64
Johannesburg 64
Toronto 64
Haiphong 63
Stockholm 63
Guangzhou 61
Chicago 59
Dearborn 59
The Dalles 59
Brussels 56
San Francisco 56
Mountain View 54
Rome 53
Jinan 51
Atlanta 50
Tashkent 49
Falkenstein 48
Baghdad 47
Phoenix 47
Poplar 46
Auburn Hills 45
Hangzhou 42
Manchester 42
Boston 40
Verona 38
Belo Horizonte 37
Norwalk 37
Des Moines 36
Guayaquil 36
Mumbai 36
Zhengzhou 36
Curitiba 35
Dong Ket 35
Ningbo 34
Nuremberg 34
Ferrara di Monte Baldo 33
San Mateo 33
Amsterdam 32
Brasília 32
Totale 38.479
Salva come PNG Salva come JPEG
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.016
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.975
A validated cellular biobank for β-thalassemia 415
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 415
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 378
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 375
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 364
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 353
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 304
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 302
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 298
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 292
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 274
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 273
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
SPR-based non-invasive prenatal testing for fetal sex determination 257
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 254
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 253
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 251
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 249
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 246
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 243
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 241
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 238
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 238
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 236
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 235
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 233
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 231
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 230
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 229
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 228
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 228
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 226
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 225
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 223
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 223
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 222
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 221
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 220
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 220
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 218
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 218
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 218
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 217
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 216
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 215
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 214
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 214
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 214
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 214
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 213
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 213
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 211
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 209
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 206
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 204
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 204
Regulation of IL-8 gene expression in gliomas by microRNAs 203
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 201
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 201
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 201
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 201
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 198
Liposomes as carriers for DNA-PNA hybrids 197
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 197
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 194
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 194
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 193
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 190
Plants with antitumor properties:from biologically active molecules to drugs 189
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 189
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 189
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 189
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 188
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 187
Cellulose acetate microparticles for Lab-on-a-chip applications 186
Alteration of microRNA biological activity with peptide nucleic acid 186
Development of microRNA based protocols for detection of autologous blood transfusion in sport 186
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 186
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 186
Cellular biosensors for the identification of fetal hemoglobin inducers 185
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 185
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 185
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 183
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 182
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 181
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites 181
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 179
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 177
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 177
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 176
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 176
Development and molecular characterization of transgenic mice for beta-thalassemia 175
Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site 175
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 175
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 174
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 173
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 172
Totale 25.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 229.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.747
Totale 236.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.084 0 0 0 0 0 0 0 0 0 0 670 414
2021/20223.168 270 279 157 105 212 161 156 139 126 279 349 935
2022/20233.300 353 266 81 444 569 447 150 298 367 33 160 132
2023/20241.875 142 262 79 49 211 366 119 87 31 30 76 423
2024/20257.091 182 189 580 355 789 556 239 381 1.199 816 955 850
2025/202622.913 1.905 791 1.605 2.377 2.748 1.285 2.384 1.167 5.634 2.270 747 0
Totale 56.590